Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients

ClinicalTrials.gov ID: NCT00440466

Public ClinicalTrials.gov record NCT00440466. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 11:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-label, Multicenter Study of Epoetin Alfa Comparing Two Extended Dosing Regimens, Once-every-two-weeks and Once-every-four-weeks, With the Once-weekly Dosing Regimen for Maintenance Treatment in Anemic Subjects With Chronic Kidney Disease

Study identification

NCT ID
NCT00440466
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Industry
Enrollment
430 participants

Conditions and interventions

Interventions

  • epoetin alfa Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2007
Primary completion
Feb 28, 2009
Completion
Feb 28, 2009
Last update posted
Apr 20, 2014

2007 – 2009

United States locations

U.S. sites
66
U.S. states
21
U.S. cities
66
Facility City State ZIP Site status
Not listed Chula Vista California
Not listed Fountain Valley California
Not listed Los Angeles California
Not listed Lynwood California
Not listed Orange California
Not listed Riverside California
Not listed San Dimas California
Not listed West Hills California
Not listed Yuba City California
Not listed Lakewood Colorado
Not listed Thornton Colorado
Not listed Washington D.C. District of Columbia
Not listed Clearwater Florida
Not listed Miami Florida
Not listed Pembroke Pines Florida
Not listed Plantation Florida
Not listed Springhill Florida
Not listed Tampa Florida
Not listed West Palm Beach Florida
Not listed Zephyrhills Florida
Not listed Atlanta Georgia
Not listed Augusta Georgia
Not listed Macon Georgia
Not listed Chicago Illinois
Not listed Evergreen Park Illinois
Not listed Peoria Illinois
Not listed Shreveport Louisiana
Not listed Baltimore Maryland
Not listed Boston Massachusetts
Not listed Methuen Massachusetts
Not listed Plymouth Massachusetts
Not listed Springfield Massachusetts
Not listed Detroit Michigan
Not listed Flint Michigan
Not listed Picayune Mississippi
Not listed St Louis Missouri
Not listed Great Neck New York
Not listed New York New York
Not listed Springfield Gardens New York
Not listed Charlotte North Carolina
Not listed Greenville North Carolina
Not listed Monroe North Carolina
Not listed Dayton Ohio
Not listed Maumee Ohio
Not listed Allentown Pennsylvania
Not listed Doylestown Pennsylvania
Not listed Erie Pennsylvania
Not listed Lancaster Pennsylvania
Not listed Philadelphia Pennsylvania
Not listed Wynnewood Pennsylvania
Not listed Providence Rhode Island
Not listed Bamberg South Carolina
Not listed Columbia South Carolina
Not listed Orangeburg South Carolina
Not listed Rock Hill South Carolina
Not listed Sumter South Carolina
Not listed Arlington Texas
Not listed Fountain Valley Texas
Not listed Houston Texas
Not listed Longview Texas
Not listed San Antonio Texas
Not listed Fairfax Virginia
Not listed Hampton Virginia
Not listed Petersburg Virginia
Not listed Richmond Virginia
Not listed Tacoma Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00440466, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2014 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00440466 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →